Kodiak Historical Balance Sheet
KOD Stock | USD 6.67 0.12 1.83% |
Trend analysis of Kodiak Sciences balance sheet accounts such as Total Current Liabilities of 30 M provides information on Kodiak Sciences' total assets, liabilities, and equity, which is the actual value of Kodiak Sciences to its prevalent stockholders. By breaking down trends over time using Kodiak Sciences balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Kodiak Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Kodiak Sciences is a good buy for the upcoming year.
Kodiak |
About Kodiak Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Kodiak Sciences at a specified time, usually calculated after every quarter, six months, or one year. Kodiak Sciences Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Kodiak Sciences and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Kodiak currently owns. An asset can also be divided into two categories, current and non-current.
Kodiak Sciences Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Kodiak Sciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Kodiak Sciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Kodiak Sciences balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Kodiak Sciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Most accounts from Kodiak Sciences' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Kodiak Sciences current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kodiak Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade Kodiak Stock refer to our How to Trade Kodiak Stock guide.At present, Kodiak Sciences' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Liabilities is expected to grow to about 120.9 M, whereas Other Current Liabilities is forecasted to decline to about 17 M.
2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 80.0M | 87.7M | 81.6M | 53.6M | Total Assets | 904.2M | 666.6M | 479.4M | 492.8M |
Kodiak Sciences balance sheet Correlations
Click cells to compare fundamentals
Kodiak Sciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Kodiak Sciences balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 358.9M | 1.1B | 904.2M | 666.6M | 479.4M | 492.8M | |
Other Current Liab | 8.7M | 18.0M | 44.4M | 23.5M | 18.4M | 17.0M | |
Total Current Liabilities | 11.7M | 31.4M | 64.7M | 52.5M | 41.7M | 30.0M | |
Total Stockholder Equity | (158.1M) | (291.2M) | (558.2M) | 436.2M | 265.8M | 279.1M | |
Other Liab | 530K | 295K | 100.1M | 100.2M | 115.2M | 120.9M | |
Net Tangible Assets | 345.4M | 860.8M | 663.3M | 436.2M | 501.6M | 358.7M | |
Property Plant And Equipment Net | 2.8M | 78.8M | 108.1M | 115.8M | 175.0M | 183.8M | |
Net Debt | (209.9M) | (867.0M) | (651.5M) | (102.7M) | (203.9M) | (214.1M) | |
Retained Earnings | (158.1M) | (291.2M) | (558.2M) | (892.0M) | (1.2B) | (1.1B) | |
Accounts Payable | 2.6M | 8.6M | 12.4M | 9.1M | 13.6M | 7.1M | |
Cash | 211.8M | 944.4M | 731.5M | 190.4M | 285.5M | 338.7M | |
Non Current Assets Total | 19.6M | 95.3M | 169.4M | 180.6M | 190.1M | 199.6M | |
Non Currrent Assets Other | 5.2M | 10.2M | 55.0M | 58.5M | 8.7M | 8.3M | |
Other Assets | 0.0 | 68.7M | 61.3M | 64.9M | 74.6M | 78.3M | |
Cash And Short Term Investments | 348.2M | 969.0M | 731.5M | 478.9M | 285.5M | 400.5M | |
Common Stock Shares Outstanding | 37.9M | 45.7M | 51.8M | 52.2M | 52.4M | 42.4M | |
Liabilities And Stockholders Equity | (144.6M) | (84.6M) | (317.3M) | 666.6M | 479.4M | 503.3M | |
Non Current Liabilities Total | 1.8M | 175.2M | 176.2M | 178.0M | 171.9M | 112.3M | |
Capital Surpluse | 503.5M | 1.2B | 1.2B | 1.3B | 1.5B | 1.6B | |
Other Current Assets | 2.7M | 6.1M | 6.6M | 7.1M | 3.8M | 4.0M | |
Other Stockholder Equity | (15K) | 1.2B | 1.2B | 1.3B | 1.4B | 1.5B | |
Total Liab | 13.5M | 206.6M | 240.9M | 230.5M | 213.6M | 142.4M | |
Property Plant And Equipment Gross | 2.8M | 78.8M | 111.0M | 122.5M | 197.6M | 207.5M | |
Total Current Assets | 339.2M | 972.0M | 734.8M | 486.0M | 289.3M | 402.0M | |
Accumulated Other Comprehensive Income | 10K | 53K | 0.0 | (1.3M) | (1.5M) | (1.6M) | |
Non Current Liabilities Other | 295K | 175.2M | 176.2M | 178.0M | 100M | 86.8M | |
Property Plant Equipment | 2.8M | 5.1M | 108.1M | 56.4M | 64.8M | 68.1M | |
Net Invested Capital | 345.4M | 860.8M | 663.3M | 436.2M | 265.8M | 408.5M | |
Net Working Capital | 327.5M | 940.6M | 670.1M | 433.5M | 247.6M | 423.9M | |
Retained Earnings Total Equity | (158.1M) | (291.2M) | (558.2M) | (892.0M) | (802.8M) | (762.7M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Kodiak Sciences is a strong investment it is important to analyze Kodiak Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Kodiak Sciences' future performance. For an informed investment choice regarding Kodiak Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kodiak Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade Kodiak Stock refer to our How to Trade Kodiak Stock guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kodiak Sciences. If investors know Kodiak will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kodiak Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.64) | Return On Assets (0.27) | Return On Equity (0.71) |
The market value of Kodiak Sciences is measured differently than its book value, which is the value of Kodiak that is recorded on the company's balance sheet. Investors also form their own opinion of Kodiak Sciences' value that differs from its market value or its book value, called intrinsic value, which is Kodiak Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kodiak Sciences' market value can be influenced by many factors that don't directly affect Kodiak Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kodiak Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kodiak Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kodiak Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.